Bioventus Inc. Share Price

Equities

BVS

US09075A1088

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
3.98 USD -2.21% Intraday chart for Bioventus Inc. -11.16% -24.48%
Sales 2024 * 528M 44.03B Sales 2025 * 562M 46.86B Capitalization 254M 21.18B
Net income 2024 * -47M -3.92B Net income 2025 * -32M -2.67B EV / Sales 2024 * 1.1 x
Net Debt 2024 * 328M 27.36B Net Debt 2025 * 273M 22.74B EV / Sales 2025 * 0.94 x
P/E ratio 2024 *
-8.04 x
P/E ratio 2025 *
-14.5 x
Employees 970
Yield 2024 *
-
Yield 2025 *
-
Free-Float 67.01%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.21%
1 week-11.16%
Current month-23.46%
1 month-22.57%
3 months-11.95%
6 months+22.46%
Current year-24.48%
More quotes
1 week
3.95
Extreme 3.95
4.60
1 month
3.95
Extreme 3.95
5.33
Current year
3.95
Extreme 3.95
6.08
1 year
0.86
Extreme 0.86
6.08
3 years
0.80
Extreme 0.7999
19.94
5 years
0.80
Extreme 0.7999
19.94
10 years
0.80
Extreme 0.7999
19.94
More quotes
Managers TitleAgeSince
Chief Executive Officer - 10/01
Director of Finance/CFO 55 21/22/21
Compliance Officer 62 -
Members of the board TitleAgeSince
Chairman 70 30/16/30
Director/Board Member 63 01/20/01
Director/Board Member 68 30/16/30
More insiders
Date Price Change Volume
26/24/26 3.98 -2.21% 128,404
25/24/25 4.07 -1.93% 71,893
24/24/24 4.15 -3.71% 118,230
23/24/23 4.31 +0.47% 99,318
22/24/22 4.29 -4.24% 144,156

Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST

More quotes
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
3.98 USD
Average target price
8 USD
Spread / Average Target
+101.01%
Consensus